ELMO2 is a therapeutic vulnerability in mesenchymal-like and drug-resistant non-small cell lung cancer
- Min Li
- Ying Xue
- Yuhan Chang
- Fan Xu
- Feizhen Wu
- Xinjian Tian
- Jie Hu
- Yijun Song
- Xufen Yu
- Fei Zhou
- Caicun Zhou
- Xin Cao
- Mei Wang
- Qihong Huang
2026-04-17